Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients
A second PSMA PET scan has been shown to alter the treatment course for nearly half of patients with prostate cancer.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
New data indicates that a second prostate-specific membrane antigen (PSMA) PET scan can lead to treatment changes for nearly 50% of prostate cancer patients. This finding highlights the utility of repeat imaging in managing the disease.
Coverage from Radiology Business, Medical Xpress, and healthcare-in-europe.com focuses on the study revealing these benefits. Additionally, Urology Times reports that updated AUA/SUO Advanced Prostate Cancer guidelines now emphasize the role of PSMA-PET.
Future developments center on the application of these updated AUA/SUO guidelines and the continued integration of PSMA-PET scans into patient care protocols.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
How many patients see a treatment change after a second PSMA PET scan?
Nearly half of prostate cancer patients experience a change in treatment.
Which medical guidelines have been updated regarding this technology?
The AUA/SUO Advanced Prostate Cancer guidelines have been updated to emphasize the role of PSMA-PET.
What does PSMA stand for in this context?
PSMA stands for prostate-specific membrane antigen.
Coverage (4)
- 2nd PET scan changes treatment for nearly half of prostate cancer patients Radiology Business · 1d ago
- Treatment change for prostate cancer: study reveals benefit of second PSMA PET healthcare-in-europe.com · 1d ago
- Updated AUA/SUO Advanced Prostate Cancer guideline emphasizes role of PSMA-PET Urology Times · 1d ago
- Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients Medical Xpress · 1d ago
Topics
Related trends
New blood test detects 90% of aggressive prostate cancer cases, beating current screenings
A new blood test called Stockholm3 is outperforming traditional PSA screenings by detecting 90% of aggressive prostate cancer cases.
Prostate cancer blood test detects twice as many cases
A new multicomponent blood test is demonstrating higher detection rates for clinically significant prostate cancer compared to traditional PSA testing.
Thousands of men with prostate cancer will now be offered high-powered radiotherapy on the NHS
The NHS is expanding access to high-powered radiotherapy for thousands of men with prostate cancer to reduce treatment times.
Jeremy Clarkson issues stark cancer warning to public: ‘Please go and get checked’
Jeremy Clarkson is urging the public to seek medical screenings after revealing his battle with aggressive prostate cancer.
A Signal of Future Alzheimer's May Be Hidden in Your Eyes
Researchers are exploring whether retinal images and AI can predict Alzheimer's risk years before symptoms appear